USPTO serial 86019802
PLASMACAP EBA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2020
- Examiner
- BIBB, SCOTT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PLASMACAP EBA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*
Plus Government fees of $2,975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher J. Schulte
Christopher J. Schulte MERCHANT & GOULD P.C.PO BOX 2910MINNEAPOLIS, MN 55402-0910United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Resins, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate ion exchange, mixed mode, and affinity resins | ACTIVE | — |
| 005 | Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins | ACTIVE | — |
| 009 | Protein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate | ACTIVE | — |
| 037 | Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing services | ACTIVE | — |
| 040 | Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics | ACTIVE | — |
| 041 | Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design of chromatography equipment, and design of biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Therapure Biopharma Inc.
- Other trademarks owned by Evolve Biologics Inc.,
- Other trademarks owned by Therapure Biopharma Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named PLASMACAP EBA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 13, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 6, 2021 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Jul 1, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 13, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jun 17, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 2, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 2, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 1, 2020 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Dec 3, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 3, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 3, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 27, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 23, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 22, 2019 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 27, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 27, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 27, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 9, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 5, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 5, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 5, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 8, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 8, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 8, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 30, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 24, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 24, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 24, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 10, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 20, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 20, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 20, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 17, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 13, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 13, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 13, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 16, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 16, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2016 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 9, 2016 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 9, 2016 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 9, 2016 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 16, 2015 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 30, 2015 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 30, 2015 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 30, 2015 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 28, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2015 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 25, 2014 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 25, 2014 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 25, 2014 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 24, 2014 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 24, 2014 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 24, 2014 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 24, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 19, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 9, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2013 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Jul 30, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 29, 2013 | NWAP | NEW APPLICATION ENTERED | — |